ZipPrime OÜ

Active Registry code 14825945 OÜ Tartu linn Registered 14 Oct 2019
Compare

ZipPrime OÜ is a OÜ based in Tartu linn, registry code 14825945, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — — — —
Q2 2023 — — — —
Q1 2023 — — — —
Q4 2022 — 44 — —
Q3 2022 16 800 — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2020 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
05 00010 00015 0002020 Company: — Industry median: 150 €20202021 Company: — Industry median: 0 €20212022 Company: 15 000 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202505 00010 00015 0002020 Company: — Industry median: 150 €2021 Company: — Industry median: 0 €20212022 Company: 15 000 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -1 625 € · −15.5% vs 2024 · industry median 0 € · above 19% of the industry
-2 00002 0004 0006 0002020 Company: -935 € Industry median: 28 €20202021 Company: -957 € Industry median: 1 €20212022 Company: 4 580 € Industry median: 0 €20222023 Company: -1 454 € Industry median: 0 €20232024 Company: -1 407 € Industry median: 0 €20242025 Company: -1 625 € Industry median: 0 €2025-2 00002 0004 0006 0002020 Company: -935 € Industry median: 28 €2021 Company: -957 € Industry median: 1 €20212022 Company: 4 580 € Industry median: 0 €2023 Company: -1 454 € Industry median: 0 €20232024 Company: -1 407 € Industry median: 0 €2025 Company: -1 625 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2022: 30.5 % · industry median 17.7 % · above 59% of the industry
0102030402020 Company: — Industry median: 23.8 %20202021 Company: — Industry median: 25.1 %20212022 Company: 30.5 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %20250102030402020 Company: — Industry median: 23.8 %2021 Company: — Industry median: 25.1 %20212022 Company: 30.5 % Industry median: 17.7 %2023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 2 392 € · −44.6% vs 2024
02 0004 0006 0008 0002020 Company: 2 501 €20202021 Company: 1 968 €20212022 Company: 7 038 €20222023 Company: 5 594 €20232024 Company: 4 317 €20242025 Company: 2 392 €202502 0004 0006 0008 0002020 Company: 2 501 €2021 Company: 1 968 €20212022 Company: 7 038 €2023 Company: 5 594 €20232024 Company: 4 317 €2025 Company: 2 392 €2025
Equity, € 2025: 1 135 € · −58.9% vs 2024
-2 000-1 00001 0002 0003 0002020 Company: -935 €20202021 Company: -1 892 €20212022 Company: 2 688 €20222023 Company: 1 234 €20232024 Company: 2 759 €20242025 Company: 1 135 €2025-2 000-1 00001 0002 0003 0002020 Company: -935 €2021 Company: -1 892 €20212022 Company: 2 688 €2023 Company: 1 234 €20232024 Company: 2 759 €2025 Company: 1 135 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -1 625 0 2 392 1 135 0
2024 0 -1 407 0 4 317 2 759 0
2023 0 -1 454 0 5 594 1 234 0
2022 15 000 4 580 0 7 038 2 688 0
2021 — -957 0 1 968 -1 892 0
2020 — -935 0 2 501 -935 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-143.2 %
Net profit / equity
Return on assets (ROA)
-67.9 %
Net profit / assets
Equity ratio
47.4 %
Equity / assets
Debt ratio
52.6 %
Liabilities / assets
Current ratio
1.90
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 23 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 1 Dec 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 8 Feb 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 7 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 26 Apr 2022 Company’s own e-Äriregister
2020 14 Oct 2019 – 31 Dec 2020 28 Jun 2021 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Sven Parkel
    Member of a senior management body (management or supervisory board) · since 14 Oct 2019

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main

Rulings 5

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50130577 / 5
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50130577 / 4
3 May 2023
 Amendment entry In force
3 May 2023
 PDF
Ä 50130577 / 3
27 Feb 2020
 Amendment entry In force
27 Feb 2020
 PDF
Ä 50130577 / 2
5 Dec 2019
 Amendment entry In force
5 Dec 2019
 PDF
Ä 50130577
14 Oct 2019
 First entry In force
14 Oct 2019
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data